Belgium Cardiac Surgery Instruments Market Report 2022 to 2030

Belgium Cardiac Surgery Instruments Market Analysis

$ 3999

The Belgium Cardiac Surgery Instruments Market is expected to witness growth from $5 Mn in 2022 to $8 Mn in 2030 with a CAGR of 6.60% for the forecasted year 2022-2030. The demand for cardiac surgery tools is rising in Belgium as cardiac diseases are becoming more common. The need for cardiac surgery instruments is expected to increase as the population ages and risk factors like smoking and obesity become more common in Belgium. The market is segmented by type, application and by end user. Some key players in this market include Trasis, Acertys Healthcare, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10BEMD004 CATEGORY: Medical Devices GEOGRAPHY: Belgium AUTHOR: Jigyasu Bhandari

Buy Now

Belgium Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Belgium Cardiac Surgery Instruments Market size is at around $5 Mn in 2022 and is projected to reach $8 Mn in 2030, exhibiting a CAGR of 6.60% during the forecast period. Belgium allotted 0.8% of its GDP in 2022 for the management and protection of the public healthcare system. As a percentage of GDP, Belgium's total health expenditure increased over time, rising from 10.5% in 2015 to 12.5% in 2020. The overall funding is higher than the EU norm. Over the past ten years, public (total) spending has increased gradually and has usually kept pace with levels in the European Union. (EU).

Belgium's leading cause of death is Cardiovascular Disease (CVD). Cardiovascular disease led to about 30.15 per cent of all deaths in Belgium in 2021. Two of the most common cardiovascular diseases in Belgium are heart failure and coronary artery disease. 20% of people in Belgium have one or more forms of CVD, making it a country with a high incidence of the condition. Adults in Belgium have high blood pressure about 25% of the time, which is a very high frequency. In Belgium, obesity, smoking, unhealthy eating, inactivity, and unhealthy diets are all CVD risk factors. The Belgian government has put in place a number of initiatives to promote healthy habits and reduce the incidence of CVD, such as prohibitions on the use of tobacco products and initiatives to promote physical activity, and improvements to the availability of wholesome foods.

In Belgium, Instruments for cardiac surgery are used in a number of cardiac medical procedures, including bypass surgery, valve replacement, and heart transplant. These tools are used by Belgian cardiothoracic surgeons and other medical workers to perform life-saving procedures on cardiac disease patients. Instruments for cardiac surgery are designed to help surgeons carry out operations with greater accuracy and precision, improving patient outcomes. Patients will feel less discomfort and recover more quickly because these tools are designed especially for accessing and operating on delicate heart tissue. Instruments for cardiac surgery are used to perform complex cardiac operations that would be difficult or impossible without them. These instruments are designed to provide surgeons with improved visibility and access to the surgical site, allowing them to perform challenging procedures with greater comfort and accuracy. In order to improve protection during operations, instruments for cardiac surgery are made. To decrease bleeding during surgery, for example, electrocautery devices and other tools can be used. Monitoring equipment can be used to spot and manage complications both during and after surgery. Cardiac surgery equipment is designed to increase efficiency during procedures while reducing recovery time and the risk of problems. Shorter medical stays, improved patient outcomes, and lower healthcare costs may result from this.

Belgium Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

The demand for cardiac surgery tools is rising in Belgium as cardiac diseases are becoming more common. The need for cardiac surgery instruments is expected to increase as the population ages and risk factors like smoking and obesity become more common. The creation of more sophisticated cardiac surgery tools that offer greater precision and safety during surgical procedures is the result of technological advancements. As a result, there is now more demand for these tools as medical workers look to enhance patient outcomes. The Belgian government has put in place a number of programs to raise the standard of healthcare services, including cardiac surgery. Due to these efforts, hospitals and medical facilities are looking to update their equipment in order to provide better patient care, which is driving demand for cardiac surgery instruments. Particularly for cardiac treatment, Belgium is a well-liked location for medical tourism. The demand for cardiac surgery equipment is likely to rise as medical facilities strive to offer the best possible care to patients from all over the globe as medical tourism continues to expand.

Market Restraints

In Belgium, there are numerous methods used to treat cardiovascular diseases, including medication and non-invasive procedures. This may in some cases lessen the need for cardiac surgery instruments. Due to Belgium's stringent regulatory environment for medical devices, manufacturers are required to adhere to exacting standards for safety and efficacy. This might restrict market expansion by preventing new producers from arriving at the market.

Competitive Landscape

Key Players

Trasis (BE)
Acertys Healthcare (BE)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

In Belgium, medical devices must bear the CE mark to demonstrate that they meet EU efficiency and safety standards. All medical equipment, including tools used in cardiac surgery, must bear the CE mark. In Belgium, medical equipment, including tools used in cardiac surgery, is governed by the Federal Agency for Medicines and Health Products (FAMHP). Before medical devices can be sold in Belgium, the organization is in charge of evaluating their efficacy and safety. In Belgium, medical devices like instruments used in cardiac surgery are subject to stringent regulations to guarantee their efficacy and safety. A collection of laws known as the Medical Device Regulation was enacted by the European Union to control medical devices, including tools used in cardiac surgery. Stricter standards for safety and efficacy, as well as post-market surveillance and clinical evaluation, are mandated by the MDR, which went into force in May 2021. To guarantee that their products are produced to the highest quality standards, manufacturers of cardiac surgery instruments in Belgium must adhere to GMP standards. All facets of the manufacturing process are covered by GMP standards, including planning, production, and quality assurance. The National Institute for Health and Disability Insurance (INAMI) in Belgium must pay for cardiac surgery tools. The amount of compensation, however, may be restricted, and medical facilities must fulfil certain requirements in order to be eligible.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Belgium market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.